Home

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

PUBLISHED Reserved 2025-11-11 | Published 2025-12-02 | Updated 2025-12-02 | Assigner icscert




HIGH: 8.7CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N

HIGH: 8.3CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L

Problem types

CWE-603

Product status

Default status
unaffected

Any version before 23.0
affected

23.0
unaffected

Credits

Joe Dillon reported these vulnerabilities to Mirion Medical. finder

References

www.cisa.gov/...vents/ics-medical-advisories/icsma-25-336-01

cve.org (CVE-2025-61940)

nvd.nist.gov (CVE-2025-61940)